financetom
Business
financetom
/
Business
/
Ulta Beauty Warrants 'More Conservative Stance' Amid Category Uncertainty, Increased Competition, Oppenheimer Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ulta Beauty Warrants 'More Conservative Stance' Amid Category Uncertainty, Increased Competition, Oppenheimer Says
Apr 4, 2024 9:28 AM

12:11 PM EDT, 04/04/2024 (MT Newswires) -- Ulta Beauty ( ULTA ) warrants a "more conservative stance" for the rest of the year due to category uncertainty and more competitive pressure, Oppenheimer said Thursday in a note to clients.

The investment firm removed the company as a top pick citing "near-term category uncertainty and an increasingly competitive beauty backdrop."

Ulta Chief Executive David Kimbell said Wednesday that the company is seeing a slowdown across categories and price cuts. "What we've seen so far is a slowdown in the total category across price points and segments. That's a bit earlier and a bit bigger than we thought," Kimbell said during a conference presentation, according to a transcript.

Oppenheimer is now estimating Ulta's 2024 diluted EPS at $26.05, down from its previous estimate of $26.45.

The investment firm said its coupon tracker shows Ulta has been a bit aggressive in terms of promoting its products lately which could lead to a more aggressive promotional environment.

Oppenheimer cut Ulta's price target to $500 from $600, with a outperform rating.

Price: 459.69, Change: +19.71, Percent Change: +4.48

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--Rubrik Guides For FY 2025 EPS Loss of $2.35-$2.25 on Revenue of $810-$824 Million, vs CIQ Analyst Consensus of $2.35/Share Loss on Revenue of $806 Million
--Rubrik Guides For FY 2025 EPS Loss of $2.35-$2.25 on Revenue of $810-$824 Million, vs CIQ Analyst Consensus of $2.35/Share Loss on Revenue of $806 Million
Jun 11, 2024
04:08 PM EDT, 06/11/2024 (MT Newswires) -- Price: 37.00, Change: +1.71, Percent Change: +4.85 ...
Celldex Therapeutics Insider Sold Shares Worth $1,586,844, According to a Recent SEC Filing
Celldex Therapeutics Insider Sold Shares Worth $1,586,844, According to a Recent SEC Filing
Jun 11, 2024
04:09 PM EDT, 06/11/2024 (MT Newswires) -- Diane C. Young, Senior Vice President, Chief Medical Officer, on June 07, 2024, sold 45,000 shares in Celldex Therapeutics ( CLDX ) for $1,586,844. Following the Form 4 filing with the SEC, Young has control over a total of 2,115 shares of the company, with 2,115 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/744218/000141588924016344/xslF345X03/form4-06112024_080650.xml ...
Celldex Therapeutics Insider Sold Shares Worth $525,873, According to a Recent SEC Filing
Celldex Therapeutics Insider Sold Shares Worth $525,873, According to a Recent SEC Filing
Jun 11, 2024
04:08 PM EDT, 06/11/2024 (MT Newswires) -- Elizabeth Crowley, Senior Vice President, Chief Product Development Officer, on June 07, 2024, sold 15,000 shares in Celldex Therapeutics ( CLDX ) for $525,873. Following the Form 4 filing with the SEC, Crowley has control over a total of 9,074 shares of the company, with 9,074 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/744218/000141588924016345/xslF345X03/form4-06112024_080653.xml ...
Onto Innovation Insider Sold Shares Worth $317,112, According to a Recent SEC Filing
Onto Innovation Insider Sold Shares Worth $317,112, According to a Recent SEC Filing
Jun 11, 2024
04:08 PM EDT, 06/11/2024 (MT Newswires) -- Srinivas Vedula, Senior Vice President, Customer Success, on June 10, 2024, sold 1,486 shares in Onto Innovation ( ONTO ) for $317,112. Following the Form 4 filing with the SEC, Vedula has control over a total of 17,433 shares of the company, with 17,433 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/704532/000202285924000025/xslF345X03/edgardoc.xml Price: 218.36, Change:...
Copyright 2023-2026 - www.financetom.com All Rights Reserved